46
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program

, , , , &
Pages 923-935 | Published online: 10 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Tadesse Asmamaw Dejenie, Markeshaw Tiruneh G/Medhin, Gashaw Dessie Terefe, Fitalew Tadele Admasu, Wondwossen Wale Tesega & Endeshaw Chekol Abebe. (2022) Current updates on generations, approvals, and clinical trials of CAR T-cell therapy. Human Vaccines & Immunotherapeutics 18:6.
Read now
PD Zavras, Y Wang, A Gandhi, K Lontos & GM Delgoffe. (2019) Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date. OncoTargets and Therapy 12, pages 4543-4554.
Read now
David L. Digiusto & Hans-Peter Kiem. (2012) Current translational and clinical practices in hematopoietic cell and gene therapy. Cytotherapy 14:7, pages 775-790.
Read now
Delphine Coulais, Clarisse Panterne, Jean-François Fonteneau & Marc Grégoire. (2012) Purification of circulating plasmacytoid dendritic cells using counterflow centrifugal elutriation and immunomagnetic beads. Cytotherapy 14:7, pages 887-896.
Read now
J. Joseph Melenhorst. (2009) Optimizing T-cell expansion: have we reached the limit?. Cytotherapy 11:7, pages 813-814.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.